Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00320476
Status:
COMPLETED
Last Update Posted:
2008-05-06
First Post:
2006-04-27
Brief Title:
VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates
Sponsor:
Korean Multiple Myeloma Working Party
Organization:
Korean Multiple Myeloma Working Party
Study Overview
Official Title:
Velcade Thalidomide Dexamethasone VTD Induction Therapy Followed By Melphalan Prednisone Thalidomide MPT Maintenance As a First Line Treatment For The Patients With Multiple Myeloma Who Are Non-Transplant Candidates
Status:
COMPLETED
Status Verified Date:
2006-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Multiple Myeloma is a incurable disease Recently developed targeted therapy gave new hope for the patients with multiple myeloma Velcade in combination with other agents are currently in trials for the newly diagnosed patient we designed sequential treatment with VTD and MPT for the patients who are not transplant candidates This would be expected to result in maximal tumor control and thus in maximal survival benefit equivalent to high dose therapy with autologous transplantation in younger population
Detailed Description:
The two effective and non-cross resistant regimens VTD and MPT will be applied sequentially to the patients with multiple myeloma who are not transplant candidates This would be expected to result in maximal tumor control and thus in maximal survival benefit equivalent to high dose therapy with autologous transplantation in younger population
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 26866138MMY2027 | None | None | None |